PRESS RELEASE
16 May 2025

Mintz Advises Olio Health In $11 Million Series B Funding Round

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mintz advised Olio Health, the leading software platform streamlining care coordination, in its closing of an $11 million Series B funding round.
United States

Mintz advised Olio Health, the leading software platform streamlining care coordination, in its closing of an $11 million Series B funding round.

Olio empowers payers, health systems, and physician groups to efficiently manage patient transitions across care settings: Skilled Nursing, Home Health, Behavioral Health, Long-Term Care, and more. Olio delivers improved outcomes and operational efficiencies, enabling organizations to engage their entire footprint at scale, addressing a critical need in the care continuum.

The Mintz team included San Francisco Office Managing Member Steve Osborn, Member Alexander Civetta, and Associates Chris Rosene, Ilse Johnson, Ryan Urban, Matthias Gallas and Brooke Siegal.

Additional information about the news is available here.

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More